$KN

Giesecke Daniel J. sold $754K of KN

Giesecke Daniel J. (Senior Vice President & COO) sold 20,201 shares of Knowles Corp (KN) at an average of $37.32 ($37.31–$37.33, $0.75M total) across 2 trades on 2026-05-27 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Giesecke Daniel J.
Published May 29, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 8:53 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$KN
Neutral
medium confidence
Mentioned
$KN
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KNNeutralLow
01

Why it matters

The newest fact is the officer’s open-market sale details (shares, price range, total value) and that it was executed under a 10b5-1 plan.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 framing reduces interpretive weight versus an unscheduled sale.

03

What to watch

The article does not provide context on total insider holdings changes over time, tax considerations, or whether other insiders sold/bought around the same period.

Relevance 4/10Novelty 3/10Timing: SEC Form 4 filed 2026-05-29, covering sales dated 2026-05-27.

Background

The article is an SEC Form 4 insider transaction disclosure for Knowles Corp (KN).

Company-level read

Ticker impact

$KNNeutralMedium confidence
Context

Knowles Corp insider Form 4 shows SVP and COO Daniel J. Giesecke sold about 20,201 shares at ~$37.32 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this disclosure; any impact is likely short-lived.

Evidence & confidence

The filing is a scheduled 10b5-1 open-market sale by an officer, with no accompanying operational or guidance change disclosed in the text.

Market effects

No sector-level implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect liquidity planning rather than bearish expectations.

Key entities

  • Knowles Corp

    US-listed company subject of the Form 4 insider sale disclosure.

  • Daniel J. Giesecke

    Senior Vice President & COO who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$KNMed

Knowles Targets 30% Margins as Specialty Components Drive Growth

Knowles Corporation (KN) aims for 30% EBITDA margins within 36 months, driven by growth in specialty components. The company reported 11% EBITDA growth from 2017-2025, with recent organic growth exceeding 10%. Precision Devices is expected to grow over 15% this year, while hearing-health margins remain above 50% gross and 40% EBITDA. Knowles plans to reduce debt and continue selective acquisitions.

$KNMed

Knowles Corp (KN): Results of Operations and Financial Condition

Knowles Corp (KN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991q22026.htm EX-99.1 Document Exhibit 99.1 Financial Contact: Sarah Cook Knowles Investor Relations Email: investorrelations@knowles.com Knowles Reports Q2 2026 Financial Results and Provides Outlook for Q3 2026 Q2 Revenues Increased 14% on a Year over Year Basi